首页 | 本学科首页   官方微博 | 高级检索  
     

乳腺癌淋巴道转移潜能与癌细胞中钙粘素及金属蛋白酶的关系
引用本文:Wang LH,Liu DY,Chen YJ,Hou L,Wang B,Mao LM,Lu S. 乳腺癌淋巴道转移潜能与癌细胞中钙粘素及金属蛋白酶的关系[J]. 癌症, 2002, 21(9): 965-969
作者姓名:Wang LH  Liu DY  Chen YJ  Hou L  Wang B  Mao LM  Lu S
作者单位:大连医科大学病理教研室,辽宁大连,116027;中国科学院大连化学物理研究所1807组,辽宁大连,116023;大连医科大学附属第二医院实验中心,辽宁大连,116027
摘    要:背景及目的:目前尚缺少有效评价乳腺癌淋巴道转移潜能的理想指标。本研究旨在通过检测上皮性钙粘素(E-cadherin,E-Cad)、神经性钙粘素(N-cadherin,N-Cad)和基质金属蛋白酶-9(matrixmetalloproteinase-9,MMP-9)基因产物在乳腺癌组织中表达的情况来探讨它们与乳腺癌浸润和转移的关系。方法:采用免疫组织化学SP方法检测E-Cad、N-Cad和MMP-9在72例乳腺浸润癌(其中淋巴结转移39例,无淋巴结转移33例)中的表达,并用多因素Cox比例风险模型分析患者的预后。结果:E-Cad表达在淋巴结转移组和无淋巴结转移组乳腺癌肿瘤细胞中的平均秩次分别为29.19,45.14,两组差异显著(P<0.001),E-Cad表达与乳腺癌转移呈负相关;N-Cad和MMP-9在淋巴结转移组乳腺癌细胞中的平均秩次分别为40.04和42.97;在无淋巴结转移组乳腺癌肿瘤细胞中的平均秩次分别为32.32和28.85。二者在淋巴结转移组与无淋巴结转移组的表达均具有显著性差异(P<0.05),与乳腺癌淋巴结转移呈正相关。E-Cad高表达者生存时间长。结论:乳腺癌的淋巴道转移与E-Cad、N-Cad和MMP-9的表达具有显著相关性,检测这几种蛋白表达将有助于判断乳腺癌的转移潜能及预后。

关 键 词:乳腺肿瘤  淋巴道转移  上皮性钙粘素  神经性钙粘素  基质金属蛋白酶-9
文章编号:1000-467X(2002)09-0965-05
修稿时间:2002-01-15

Relationship between lymph node metastasis and the expressions of E-cadherin,N-cadherin,and matrix metalloproteinase in breast carcinoma
Wang Li-hui,Liu Da-yu,Chen Ying-jie,Hou Li,Wang Bo,Mao Li-min,Lu Shen. Relationship between lymph node metastasis and the expressions of E-cadherin,N-cadherin,and matrix metalloproteinase in breast carcinoma[J]. Chinese journal of cancer, 2002, 21(9): 965-969
Authors:Wang Li-hui  Liu Da-yu  Chen Ying-jie  Hou Li  Wang Bo  Mao Li-min  Lu Shen
Affiliation:Department of Pathology, Dalian Medical University, Dalian 116027, P. R. China. lihui1009@163.net
Abstract:BACKGROUND & OBJECTIVE: There is little ideal predictor available on evaluating the lymph node metastatic potential of breast carcinoma. This study was designed to determine the expression of gene products of E-cadherin (epithelial), N-cadherin (nerve), and matrix metalloproteinase-9 (MMP-9) in breast carcinoma tissue and investigate their association with the invasion and metastasis of breast carcinoma. METHODS: The authors examined the expressions of E-cadherin, N-cadherin, and MMP-9 in 72 cases of breast carcinoma(39 cases with lymph node metastasis and 33 cases without lymph node metastasis) by immunohistochemistry. Multivariable Cox proportional hazards model was used to analyze the patients' prognosis. RESULTS: The average ranks of E-cadherin in lymph node metastasis group and no lymph node metastasis group were 29.19 and 45.14, respectively, with significant difference (P < 0.001). The expression of E-cadherin was correlated inversely with the metastasis of breast carcinoma. The average ranks of N-cadherin and MMP-9 were 40.04 and 42.97 in lymph node metastasis group, and 32.32 and 28.85 in no lymph node metastasis group, both with significant difference (P < 0.05), and these expressions were positively correlated with the lymph node metastasis of breast carcinoma. The patients who had high expression of E-cadherin had a longer survival time. CONCLUSION: Expression of E-cadherin, N-cadherin, and MMP-9 are associated strongly with lymph node metastasis of breast carcinoma. These proteins are indicators of metastasis potential and prognosis of breast carcinoma.
Keywords:Breast carcinoma  Lymph node metastasis  E-Cadherin  N-Cadherin  Matr ix metalloproteinase-9
本文献已被 CNKI 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号